Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Robert Paridaens, Luc Yves Dirix, Caroline A. Lohrisch et al. · Annals of Oncology · 2003

Cited by 230 works. doi:10.1093/annonc/mdg362

Authors

References